Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
BioAtla, Inc. - Common Stock
(NQ:
BCAB
)
0.4142
-0.0180 (-4.16%)
Streaming Delayed Price
Updated: 10:27 AM EDT, May 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BioAtla, Inc. - Common Stock
< Previous
1
2
3
4
Next >
Analyst Ratings for BioAtla
September 25, 2023
Via
Benzinga
BioAtla to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
September 06, 2023
From
BioAtla, Inc.
Via
GlobeNewswire
BioAtla to Participate in Upcoming Investor Conferences in August
August 03, 2023
From
BioAtla, Inc.
Via
GlobeNewswire
The Latest Analyst Ratings for BioAtla
August 02, 2023
Via
Benzinga
BioAtla Reports Second Quarter 2023 Financial Results and Highlights Recent Progress
August 01, 2023
From
BioAtla, Inc.
Via
GlobeNewswire
Where BioAtla Stands With Analysts
May 15, 2023
Via
Benzinga
Expert Ratings for BioAtla
March 24, 2023
Via
Benzinga
Earnings Outlook For BioAtla
March 22, 2023
Via
Benzinga
BioAtla to Announce Second Quarter 2023 Financial Results and Provide Business Highlights on August 1, 2023
July 25, 2023
From
BioAtla, Inc.
Via
GlobeNewswire
BioAtla Added to Membership of U.S. Small-Cap Russell 2000® Index
June 26, 2023
From
BioAtla, Inc.
Via
GlobeNewswire
BioAtla to Participate in the Jefferies Healthcare Conference
May 31, 2023
From
BioAtla, Inc.
Via
GlobeNewswire
BioAtla Reports First Quarter 2023 Financial Results and Highlights Recent Progress
May 11, 2023
From
BioAtla, Inc.
Via
GlobeNewswire
BioAtla to Participate in the JMP Securities Life Sciences Conference
May 08, 2023
From
BioAtla, Inc.
Via
GlobeNewswire
BioAtla to Announce First Quarter 2023 Financial Results and Provide Business Highlights on May 11, 2023
May 04, 2023
From
BioAtla, Inc.
Via
GlobeNewswire
Around $1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
March 31, 2023
The Dow Jones closed higher by more than 100 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or ...
Via
Benzinga
BioAtla Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Progress
March 23, 2023
From
BioAtla, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 23, 2023
March 23, 2023
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter.
Via
Benzinga
BioAtla to Announce Fourth Quarter and Full-Year 2022 Financial Results and Provide Business Highlights
March 16, 2023
From
BioAtla, Inc.
Via
GlobeNewswire
BioAtla Announces Change in Executive Leadership
February 27, 2023
From
BioAtla, Inc.
Via
GlobeNewswire
BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3182, a CAB-EpCAMxCAB-CD3 Bispecific T-Cell Engager for the Treatment of Advanced Adenocarcinoma
February 23, 2023
From
BioAtla, Inc.
Via
GlobeNewswire
Dow Rises Over 100 Points; Rayonier Advanced Materials Shares Plunge
January 10, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 100 points on Tuesday. The Dow traded up 0.40% to 33,653.27 while the NASDAQ rose 0.83% to 10,724.37. The S&P...
Via
Benzinga
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 10, 2023
Gainers
Via
Benzinga
Crude Oil Rises Over 1%; Oak Street Health Shares Spike Higher
January 10, 2023
U.S. stocks traded slightly higher midway through trading, with the Dow Jones around than 30 points on Tuesday.
Via
Benzinga
US Stocks Open Higher; Nasdaq Rises 50 Points
January 10, 2023
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 50 points on Tuesday.
Via
Benzinga
BioAtla Provides Clinical Program Updates and Upcoming 2023 Milestones
January 10, 2023
From
BioAtla, Inc.
Via
GlobeNewswire
BioAtla to Participate in the 41st Annual J.P. Morgan Healthcare Conference
December 22, 2022
From
BioAtla, Inc.
Via
GlobeNewswire
BioAtla to Participate in the Jefferies London Healthcare Conference
November 08, 2022
From
BioAtla, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via
Benzinga
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
November 07, 2022
Gainers
Via
Benzinga
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
November 04, 2022
Gainers
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.